Vitrase: profile and news

ISTA Pharmaceuticals Reports Simple Model Predicts Treatment ...  May 1, 2006
...today details of two scientific poster presentations that describe the first predictive model for treatment success with Vitrase® (Ovine Hyaluronidase) in ... - Yahoo! News (press release)

ISTA Pharmaceuticals, Inc. Reports First Quarter 2006 Financial ...  May 8, 2006
Net product sales for the first quarter of 2006 included Xibrom(TM) net sales of $2.9 million, Istalol® net sales of $1.8 million and Vitrase® net sales of ... - Yahoo! News (press release)

ISTA Pharmaceuticals Q1 Net Loss Widens Despite Higher Revenues ...  May 8, 2006
The fee is attributable to recognition of license fee payment received from Otsuka Pharmaceutical Co. for the license for Vitrase in Japan. ... - Trading Markets,

Allergan Reports First Quarter Operating Results; Pharmaceutical ...  May 3, 2006
...of $15.7 million and the tax effect for non-GAAP adjustments of $5.3 million (h) Transition/duplicate operating expenses (i) ISTA Vitrase collaboration fee (j ... - Genetic Engineering News,

(PRN) - Webcast Alert: Perceptron, Inc. Announces Third Quarter ...  May 1, 2006
...[+]. (PRN) - ISTA Pharmaceuticals Reports Simple Model Predicts Treatment Success With Vitrase(R) in Vitreous Hemorrhage Associated With Diabetes ... [+. ... - Bolsamania.com,